Clinical trial
Impact of TECAR Therapy in Treatment of Post-natal Rectus Diastasis
NCT05287282 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of TECAR Therapy in Treatment of Post-natal Rectus Diastasis
- Lead sponsor
- Cairo University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2022
- Completion date
- September 30, 2022
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rectus diastasis